HomeCompareIOTC vs JNJ

IOTC vs JNJ: Dividend Comparison 2026

IOTC yields 181818.18% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IOTC wins by $1.8951031795759825e+29M in total portfolio value
10 years
IOTC
IOTC
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full IOTC calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — IOTC vs JNJ

📍 IOTC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIOTCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IOTC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IOTC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IOTC
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, IOTC beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IOTC + JNJ for your $10,000?

IOTC: 50%JNJ: 50%
100% JNJ50/50100% IOTC
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IOTC
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IOTC buys
0
JNJ buys
0
No recent congressional trades found for IOTC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIOTCJNJ
Forward yield181818.18%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1.8951031795759825e+29M$30.5K
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00$4,749.88
Total dividends collected$1.8949690612486723e+29M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IOTC vs JNJ ($10,000, DRIP)

YearIOTC PortfolioIOTC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$18,192,518$18,181,818.18$10,594$274.49+$18.18MIOTC
2$30,932,835,887$30,913,369,892.64$11,294$360.69+$30932.82MIOTC
3$49,156,619,660,049$49,123,521,525,649.34$12,133$476.91+$49156619.65MIOTC
4$73,009,768,971,452,110$72,957,171,388,415,860.00$13,156$635.42+$73009768971.44MIOTC
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$14,432$854.61+$101348671691011.75MIOTC
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$16,056$1,162.76+$131490628941834960.00MIOTC
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$18,175$1,604.53+$159445709700484431872.00MIOTC
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$21,009$2,252.68+$1.8070656065589233e+23MIOTC
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$24,911$3,229.73+$1.9141674430419936e+26MIOTC
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$30,458$4,749.88+$1.8951031795759825e+29MIOTC

IOTC vs JNJ: Complete Analysis 2026

IOTCStock

Iota Communications, Inc., through its subsidiaries, provides Internet of Things (IoT) solutions. It also provides energy conservation solutions. The company operates through Iota Networks, Iota Commercial Solutions, Iota Communications, and Iota Holdings. In addition, the company offers delphi360, a wireless connectivity and data analytics platform to integrate with devices and sensors, as well as provides BrightAI, an analytic platform that gathers information from sensor connectivity. Further, it provides IoT-based LED and smart lighting. Additionally, it offers smart building solutions, a platform for data management. Furthermore, the company serves healthcare, commercial real estate, education, utility, retail, and manufacturing industries; and city and municipals. Iota Communications, Inc. is based in Allentown, Pennsylvania.

Full IOTC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this IOTC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IOTC vs SCHDIOTC vs JEPIIOTC vs OIOTC vs KOIOTC vs MAINIOTC vs ABBVIOTC vs MRKIOTC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.